612 related articles for article (PubMed ID: 26178990)
21. MVA-Vectored Pentameric Complex (PC) and gB Vaccines Improve Pregnancy Outcome after Guinea Pig CMV Challenge, but Only gB Vaccine Reduces Vertical Transmission.
Contreras H; Wussow F; Fernández-Alarcón C; Bierle C; Nguyen J; Diamond DJ; Schleiss MR
Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31739399
[TBL] [Abstract][Full Text] [Related]
22. Protection against Congenital CMV Infection Conferred by MVA-Vectored Subunit Vaccines Extends to a Second Pregnancy after Maternal Challenge with a Heterologous, Novel Strain Variant.
Fernández-Alarcón C; Buchholz G; Contreras H; Wussow F; Nguyen J; Diamond DJ; Schleiss MR
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960820
[TBL] [Abstract][Full Text] [Related]
23. A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection.
Crumpler MM; Choi KY; McVoy MA; Schleiss MR
Vaccine; 2009 Jun; 27(31):4209-18. PubMed ID: 19389443
[TBL] [Abstract][Full Text] [Related]
24. Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model.
Olejniczak MJ; Choi KY; McVoy MA; Cui X; Schleiss MR
Virol J; 2011 Mar; 8():89. PubMed ID: 21371319
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI
Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996
[TBL] [Abstract][Full Text] [Related]
26. Vaccination for the prevention of maternal and fetal infection with guinea pig cytomegalovirus.
Bia FJ; Griffith BP; Tarsio M; Hsiung GD
J Infect Dis; 1980 Nov; 142(5):732-8. PubMed ID: 6257798
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model.
Choi KY; El-Hamdi NS; McGregor A
Vaccine; 2020 Feb; 38(10):2340-2349. PubMed ID: 32008881
[TBL] [Abstract][Full Text] [Related]
28. Cloning and expression of the guinea pig cytomegalovirus glycoprotein B (gB) in a recombinant baculovirus: utility for vaccine studies for the prevention of experimental infection.
Schleiss MR; Jensen NJ
J Virol Methods; 2003 Mar; 108(1):59-65. PubMed ID: 12565154
[TBL] [Abstract][Full Text] [Related]
29. Low maternal CD4 count at inception of gestational cytomegalovirus (CMV) infection and impaired humoral response: effect on congenital CMV infection in the guinea pig.
Harrison CJ; Burger R
Clin Immunol Immunopathol; 1991 Aug; 60(2):171-80. PubMed ID: 1676941
[TBL] [Abstract][Full Text] [Related]
30. Convalescent Immunity to Guinea Pig Cytomegalovirus Induces Limited Cross Strain Protection against Re-Infection but High-Level Protection against Congenital Disease.
Choi KY; El-Hamdi NS; McGregor A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825429
[TBL] [Abstract][Full Text] [Related]
31. Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV).
Schleiss MR
J Clin Virol; 2002 Aug; 25 Suppl 2():S37-49. PubMed ID: 12361755
[TBL] [Abstract][Full Text] [Related]
32. Cross Strain Protection against Cytomegalovirus Reduces DISC Vaccine Efficacy against CMV in the Guinea Pig Model.
Choi KY; El-Hamdi NS; McGregor A
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458490
[TBL] [Abstract][Full Text] [Related]
33. Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta.
Hashimoto K; Yamada S; Katano H; Fukuchi S; Sato Y; Kato M; Yamaguchi T; Moriishi K; Inoue N
Vaccine; 2013 Jun; 31(31):3199-205. PubMed ID: 23684839
[TBL] [Abstract][Full Text] [Related]
34. Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model.
Schleiss MR; Anderson JL; McGregor A
Virol J; 2006 Mar; 3():9. PubMed ID: 16509982
[TBL] [Abstract][Full Text] [Related]
35. Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection.
Bravo FJ; Cardin RD; Bernstein DI
J Infect Dis; 2006 Feb; 193(4):591-7. PubMed ID: 16425139
[TBL] [Abstract][Full Text] [Related]
36. Endothelial Cell Infection by Guinea Pig Cytomegalovirus Is a Lytic or Persistent Infection Depending on Tissue Origin but Requires Viral Pentamer Complex and pp65 Tegument Protein.
Choi KY; El-Hamdi N; McGregor A
J Virol; 2022 Sep; 96(17):e0083122. PubMed ID: 36000848
[TBL] [Abstract][Full Text] [Related]
37. Effect of passive antibody on congenital cytomegalovirus infection in guinea pigs.
Bratcher DF; Bourne N; Bravo FJ; Schleiss MR; Slaoui M; Myers MG; Bernstein DI
J Infect Dis; 1995 Oct; 172(4):944-50. PubMed ID: 7561214
[TBL] [Abstract][Full Text] [Related]
38. Requirements for guinea pig cytomegalovirus tropism and antibody neutralization on placental amniotic sac cells.
Choi KY; El-Hamdi NS; McGregor A
J Gen Virol; 2020 Apr; 101(4):426-439. PubMed ID: 32068527
[TBL] [Abstract][Full Text] [Related]
39. The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.
Schleiss MR; Bernstein DI; McVoy MA; Stroup G; Bravo F; Creasy B; McGregor A; Henninger K; Hallenberger S
Antiviral Res; 2005 Jan; 65(1):35-43. PubMed ID: 15652969
[TBL] [Abstract][Full Text] [Related]
40. Effects of vaccination on cytomegalovirus-associated interstitial pneumonia in strain 2 guinea pigs.
Bia FJ; Lucia HL; Fong CK; Tarsio M; Hsiung GD
J Infect Dis; 1982 May; 145(5):742-7. PubMed ID: 6281341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
